67 related articles for article (PubMed ID: 23344084)
1. Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study.
Chapdelaine I; Goupil R; Azcoitia V; Rioux JP; Raymond-Carrier S; Madore F; Troyanov S
Nephron Clin Pract; 2012; 121(3-4):c174-9. PubMed ID: 23344084
[TBL] [Abstract][Full Text] [Related]
2. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure-related genes and the progression of IgA nephropathy.
Kim SM; Chin HJ; Oh YK; Kim YS; Kim S; Lim CS
Nephron Clin Pract; 2009; 113(4):c301-8. PubMed ID: 19729965
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
[TBL] [Abstract][Full Text] [Related]
5. Genetic risk score and risk of stage 3 chronic kidney disease.
Ma J; Yang Q; Hwang SJ; Fox CS; Chu AY
BMC Nephrol; 2017 Jan; 18(1):32. PubMed ID: 28103844
[TBL] [Abstract][Full Text] [Related]
6. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
7. Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms.
Nakayama Y; Nonoguchi H; Kohda Y; Inoue H; Memetimin H; Izumi Y; Tomita K
Nephron Clin Pract; 2009; 111(4):c240-6. PubMed ID: 19293592
[TBL] [Abstract][Full Text] [Related]
8. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency.
Coll E; Campos B; González-Núñez D; Botey A; Poch E
J Nephrol; 2003; 16(3):357-64. PubMed ID: 12832734
[TBL] [Abstract][Full Text] [Related]
9. Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
Park HC; Choi HY; Kim BS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Kidney Blood Press Res; 2006; 29(4):216-24. PubMed ID: 16960460
[TBL] [Abstract][Full Text] [Related]
10. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
Kacso I; Gherman M; Mazouz H; Ghazali A; el Esper N; Morinière P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
Nephrologie; 1999; 20(1):19-28. PubMed ID: 10081033
[TBL] [Abstract][Full Text] [Related]
11. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
13. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study.
Verhave JC; Bouchard J; Goupil R; Pichette V; Brachemi S; Madore F; Troyanov S
Diabetes Res Clin Pract; 2013 Sep; 101(3):333-40. PubMed ID: 23880038
[TBL] [Abstract][Full Text] [Related]
16. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients.
Fradin S; Goulet-Salmon B; Chantepie M; Grandhomme F; Morello R; Jauzac P; Reznik Y
Diabetes Metab; 2002 Feb; 28(1):27-32. PubMed ID: 11938025
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function--a single-center experience.
Siekierka-Harreis M; Kuhr N; Willers R; Ivens K; Grabensee B; Mondry A; Loh MC; Rump LC; Blume C
Clin Transplant; 2009; 23(5):606-15. PubMed ID: 19681973
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.
Konta T; Ikeda A; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Yoshida H; Asahi K; Kurahashi I; Ohashi Y; Watanabe T
Am J Hypertens; 2012 Mar; 25(3):342-7. PubMed ID: 22089103
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for proteinuria: the National Kidney Foundation of Malaysia Lifecheck Health Screening programme.
Ong LM; Punithavathi N; Thurairatnam D; Zainal H; Beh ML; Morad Z; Lee SY; Bavanandan S; Kok LS
Nephrology (Carlton); 2013 Aug; 18(8):569-75. PubMed ID: 23782264
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and the risk of progression of chronic kidney disease.
Khedr A; Khedr E; House AA
J Ren Nutr; 2011 Nov; 21(6):455-61. PubMed ID: 21454093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
